SCHEMBL23635882

SCHEMBL23635882

CCOC(=O)c1sc2cccc(F)c2c1COc1ccc(C(N)=O)c(C(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
KDM4E B2RXH2 4/20 0.52
HPGD P15428 4/20 0.52
GLA P06280 1/20 0.52
GAA P10253 1/20 0.52
TSHR P16473 1/20 0.52
HSD17B10 Q99714 1/20 0.52
STING1 Q86WV6 7/20 0.49
LMNA P02545 4/20 0.42
PARP10 Q53GL7 3/20 0.41
PARP15 Q460N3 2/20 0.41
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
THRB P10828 1/20 0.39
MAPK10 P53779 1/20 0.38
PARP14 Q460N5 1/20 0.37
MEN1 O00255 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23635831 0.89 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL23635859 0.88 STING1 (0.60) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL23635832 0.88 STING1 (0.55) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL30313238 0.83 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL23635796 0.83 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL26778192 0.83 STING1 (0.49) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL30697680 0.82 STING1 (0.62) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL23635887 0.82 STING1 (0.62) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL23635892 0.81 MAOB (0.50) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL26778556 0.80 STING1 (0.43) STING1PARP10PARP15MAPK10PARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD. (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 ALDH1A1 4660/4885KDM4E 1469/4885HPGD 4047/4885
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 ALDH1A1 4719/4885KDM4E 1519/4885HPGD 4013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.